Matthew McIlwain
Independent DirectorMr. Matthew McIlwain, also known as Matt, is Director of DVx Atomic Co. from September 2026. Mr. McIlwain serves as Managing Director at Madrona Venture Group, LLC since June 2002. He joined the firm as a Venture Partner in June 2000 and focuses on software driven companies. He is Strategic Advisor of Generative Capital. He serves as Chairman of Advisory Board at Fred Hutchinson Cancer Center since 2026. He serves as Director of Suplari, Inc., Placed, Inc., Mixpo Inc., Skytap, Inc. since 2006, Animoto Inc., Optify, Inc., Mixpo Portfolio Broadcasting Inc., Ollion, Inc. since December 21, 2012, Qumulo, Inc. since February 2015, Igneous Systems, Inc., Amperity, Inc., Booster Fuels, Inc., TerraClear, Inc., A-Alpha Bio, Inc., EdgeRunner AI, Inc. from May 2025, Modulus Therapeutics, Inc., Proof Diagnostics, Inc., Read AI, Inc., Panorama Artificial Intelligence Corp., PetraVM and XNOR.ai. He is an Independent Director of Nautilus Biotechnology, Inc. since June 9, 2021 and Outside Director of Tier 3, Inc. He was an Investor & Advisor at Garden City Management, LLC. Mr. McIlwain is a Member of the Executive Board at OneTeam Collective and a Board Member of Washington Policy Center. His prior roles include serving as Co-Chairman of the Advisory Board at Fred Hutchinson Cancer Center until 2026, as a Member of the Advisory Board from September 2022 and as Chairman. He served as an Independent Director of Smartsheet Inc. from May 2007 to 2025. He served as a Director at Apptio, Inc. from November 2007 to 2019, where he also served as a Managing Director. He served on the Old Nautilus board of directors from January 2021 to June 9, 2021. He was Vice President of Business Process for the Genuine Parts Company from January 1996 to May 2000. He served as an Engagement Manager at McKinsey & Company, Inc. from August 1992 to December 1995 and worked in investment banking at Credit Suisse First Boston. He also served as a Director of Turi Inc., Farecast, Inc., ExtraHop Networks, Inc., World Wide Packets, Inc., Vykor, Inc., iConclude Co., PayScale, Inc., Appature, Inc., OffAndAway, Inc., Performant Inc., WorldCatch Foods, LLC, Washington Technology Industry Association, Credit Suisse Securities (USA) LLC, WorldCatch Foods, LLC, Nimble, CenturyLink Cloud, Inc. and Isilon Systems, Inc. from May 2001 to April 18, 2007 and from February 2008. He was a Board Observer of Accolade, Inc. from November 9, 2017 to 2021. Mr. McIlwain has extensive venture capital leadership experience and expertise in identifying emerging technologies and scaling opportunities. He helps technology companies refine their product-market fit and develop sustainable competitive advantages. He was named to the Forbes Midas List in 2008, 2009 and 2011, received the Washington Policy Center's Champion of Freedom Award in 2011 and was awarded Director of the Year from the NACD and Puget Sound Business Journal in 2017. He Co-teaches a course on venture capital in the University of Washington Technology M.B.A. Program. He holds an M.B.A. from Harvard Business School (1990-1992), an M.P.P from John F. Kennedy School of Government and a B.A. in Economics & Government from Dartmouth College (1983-1987).
Positions
- Company NameNautilus Biotechnology, Inc.Stock CodeNAUTPositionIndependent DirectorColleagues
- SMSujal M. PatelCo-Founder, CEO, President, Secretary & Director
- MLMatthew L. PosardIndependent Chairman of the Board
- PMParag MallickCo-Founder, Chief Scientist & Director
- AMAnna MowryCFO & Treasurer
- MBMatthew B. MurphyGeneral Counsel
- AFAmber FaustVice President of Global Sales
- MBMelissa B. EpperlyIndependent Director
